HomeAll ContractsContract
TANGEN SARS-COV-2 ASSAY
Total Committed
$696K
Product or Service Description
Biomedical Advanced Development R&D
Total Potential Value
$696K
Effective Date
April 15, 2020
Funding Department
OFFICE OF ACQ&MGMT POLICY
Type
Firm fixed price
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Vendor Description Signed Reason for Change Amount Committed
TANGEN BIOSCIENCES, INC. TANGEN SARS-COV-2 ASSAY - NCE TO ALLOW TIME FOR THE EUA TO MOVE THROUGH FDA APPROVAL. Sept. 21, 2020 Change Order $0
TANGEN BIOSCIENCES, INC. TANGEN SARS-COV-2 ASSAY Aug. 14, 2020 Change Order $0
TANGEN BIOSCIENCES, INC. TANGEN SARS-COV-2 ASSAY April 15, 2020 $696,000
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page